Weekly Outlook

• Abbott Laboratories stock declined by 1.38% over the past week, closing at $94.12. • The price action indicates that sellers currently dominate the market, keeping the stock value below major moving averages. • This downward trend suggests a bearish sentiment among investors, as the stock struggles to find support above key technical levels.

• Salesforce stock declined 1.12% this week, closing at $163.93 as bearish momentum continues to dominate the price action. • Despite strong fundamentals, including $11.13 billion in revenue (up 13.3% year-over-year) and earnings per share of $3.88, technical indicators remain weak. • The stock is currently trading below key moving averages, signaling a lack of bullish reversal and suggesting that sellers maintain control.

• The EUR/JPY currency pair experienced a decline to 183.14 last week before seeing a partial recovery. • Analysts view the drop from 186.30 as the third leg of a larger pattern originating from the 187.93 level. • The current market bias remains neutral, with a critical support level identified at 182.01.

• Stock markets are trending toward modest weekly gains despite a recent sell-off triggered by the Federal Open Market Committee (FOMC). • Market recovery is being driven by a combination of stabilizing yields and a decline in oil prices, which has encouraged investors to engage in dip buying. • This shift indicates a transition from immediate volatility to a more stabilized outlook as traders react to central bank signals.